Irving Consumer Products has unveiled a plan to construct its new tissue production facility in Macon, Georgia with an investment of $400m.
Engineering and planning for the facility is currently under progress. Construction will commence this summer and is scheduled to be concluded in 2019.
Once completed, the new plant would double Irving Consumer Products’ ThruAir Dry production capacity, increasing it by 75,000 tonnes, the equivalent of 15 million cases.
The new plant will create more than 200 jobs. During peak construction period, the project will create more than 540 jobs.
Irving Consumer Products president Robert Irving said: “We're pleased to be expanding our business in the US. We're excited by the opportunity in Macon and in Georgia. We're looking forward to building a strong relationship with the wonderful people of this community.
“Selecting Macon for our new facility provides us with an opportunity to establish a footprint in a region that has proven itself as being a strong supporter of business. It will allow us to reach key markets, and will help to continue to drive our growth.
“This expansion is possible because of the commitment of our employees, customers and suppliers. It is their support that has allowed us to grow and expand."
